Company: OTSA
Filing Date: 2025-03-26
Form Type: DRS/A
Source: 0001013762-25-002776
Chunk: 147

Company: OTSAW Ltd
Filing Date: 2025-03-26
Form: DRS/A
Chunk 147
---
 and to tailor Odyssey’s applications to their unique needs and product design. Not only will the Odyssey provide an additional source of revenue by leveraging our existing software and AI technology, we believe that by commercializing software technology to other robots and AMRs manufacturers and developers, it will provide us with the means to be a prominent AI and AMR software solution provider to the entire robotic industry. We believe the world is entering a new era where robots will become increasingly prevalent in all sectors, and thus we believe the Odyssey will expand our ecosystem coverage by integrating our core software technologies with all relevant players in the robotics industry. By licensing our software technologies to the pool of players in the robotics industry, the Odyssey, as an all -in -oneANS, opens up numerous applications and tremendous monetization opportunities that go beyond our current product offering. We envision the Odyssey to become the dominant ANS that represents the future trend for autonomous robotics software technology. Expansion of Our Production Capacity for Cost-Efficient Manufacturing and Competitive Pricing We intend to expand the production capacity of our AMRs. With our organic growth, the increasing popularity of our products, the joint ventures with Swisslog Healthcare, the expansion of our distributor network and channels and other potential strategic partnerships with various industry leaders, we expect an increase in orders for our AMRs, UV -Cdisinfection systems, and other products globally and a continuous rise in sales volume in the future. Our goal is to expand our production capacity to have at least three months of finished products as the inventory to sell/lease at any given time. Expanding our production capacity enables us to meet our projected demand. This will lower manufacturing costs through economies of scale and improve overall cost -efficiencyand profit margins. Ultimately, we will be able to provide our AMR and robotics solutions at a competitive price. This is important especially to cost -sensitivecustomers in the facilities management industries, who are relatively new to the concept of reducing human reliance. Furthermore, expanding our production capacity bolsters our inventory and insulates our production from supply chain constraints and operational disruptions. Supply chain logistics and spare parts procurement and logistics (such as semiconductors, batteries, and sensors) has been challenging due to the COVID -19and geo -politicsconstraints, historically high demand, and geopolitical supply chain crises. The expansion of our production capacity may minimize the risk involved in the timely delivery of our products to consumers. Current Production Capacity Our Singapore facility currently operates at an estimated production capacity of 3 units per month, based on a one team,